文献速递血管炎

影像学预测大血管型巨细胞动脉炎患者停药后早期复发——一项队列研究

Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis - A cohort study.
PubMed 文献 · Semin Arthritis Rheum · 2024-02-28

该队列研究纳入2018至2023年间停药的大血管型巨细胞动脉炎患者40例,评估停药时PET/CT和/或MRI对停药后4个月内复发的预测价值。结果显示复发组与未复发组在MRI和/或PET/CT活动性血管炎表现、MRI血管炎节段数及最高SUV动脉/肝脏比值上均无显著差异,PET/CT或MRI不能预测复发,可能不适用于指导缓解期LV-GCA患者的治疗决策。

要点

  • 停药时PET/CT或MRI活动性血管炎表现不能预测大血管型巨细胞动脉炎停药后复发。
  • 复发组与未复发组MRI血管炎节段数及PET/CT最高SUV动脉/肝脏比值均无显著差异。
  • PET/CT或MRI可能不适用于指导缓解期LV-GCA患者的治疗决策。

核心结论

  • 停药时PET/CT或MRI不能预测复发,可能不适用于指导缓解期大血管型巨细胞动脉炎患者的治疗决策。

研究设计与样本

  • 研究纳入2018至2023年间停药的大血管型巨细胞动脉炎患者,共40例,中位年龄67.4岁(IQR 60.8-74.0),女性占77.5%。
  • 所有患者在临床缓解停药时接受PET/CT和/或MRI检查,比较停药后4个月内复发与未复发患者的定性和定量PET/CT评分及半定量MRI评分。

主要发现

  • 11例(27.5%)在停药后复发,复发时间1.9个月(IQR 1.4-3.3)。
  • 复发组与未复发组MRI和/或PET/CT存在活动性血管炎的比例分别为54.5%与58.6%(p=1.0),无显著差异。
  • 复发组与未复发组MRI血管炎节段数分别为0(IQR 0.0-1.5)与2(IQR 0.0-3.0)(p=0.221),无显著差异。
  • 复发组与未复发组PET/CT最高SUV动脉/肝脏比值分别为1.5(IQR 1.4-1.6)与1.3(IQR 1.2-1.6)(p=0.505),无显著差异。
  • 复发组与未复发组PET/CT血管炎节段数中位数分别为2.5(IQR 0.5-4.5)与0(IQR 0.0-1.5)(p=0.085),PET/CT评分分别为4.5(IQR 0.75-8.25)与0(IQR 0.0-3.0)(p=0.172)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) in predicting relapse after treatment discontinuation in patients with large-vessel giant cell arteritis (LV-GCA). METHODS: This study included patients with LV-GCA whose treatment was discontinued between 2018 and 2023. All patients underwent PET/CT and/or MRI at the time of treatment discontinuation in clinical remission. Qualitative and quantitative PET/CT scores, by measuring standardized uptake values (SUV), and semiquantitative MRI scores of the aorta and supraaortic vessels were compared between patients who relapsed within 4 months after treatment discontinuation and those who did not. RESULTS: Forty patients were included (median age 67.4 years, interquartile range (IQR) 60.8-74.0; 77.5 % females). Eleven patients (27.5 %) relapsed after treatment discontinuation (time to relapse 1.9 months, IQR 1.4-3.3). Patients who relapsed were comparable to those who remained in remission with respect to the presence of active vasculitis on MRI and/or PET/CT (54.5% vs. 58.6 %, p = 1.0), the number of segments with vasculitic findings on MRI (0, IQR 0.0-1.5, vs. 2, IQR 0.0-3.0, p = 0.221) or the highest SUV artery/liver ratio on PET/CT (1.5, IQR 1.4-1.6, vs. 1.3, IQR 1.2-1.6, p = 0.505). The median number of vasculitic segments on PET/CT was 2.5 (IQR 0.5-4.5) in those with vs. 0 (IQR 0.0-1.5, p = 0.085) in those without relapse, and the PET/CT scores 4.5 (IQR 0.75-8.25) vs. 0 (IQR 0.0-3.0, p = 0.172). CONCLUSION: PET/CT or MRI at treatment stop did not predict relapse and may not be suited to guide treatment decisions in patients with LV-GCA in remission.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Hemmig AK, Rottenburger C, Baruti L, et al. Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis - A cohort study. Semin Arthritis Rheum. 2024. PMID: 38442463. doi:10.1016/j.semarthrit.2024.152425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。